The ESTxENDS Trial: Pulmonary Function Substudy

NACompletedINTERVENTIONAL
Enrollment

130

Participants

Timeline

Start Date

April 10, 2019

Primary Completion Date

February 28, 2022

Study Completion Date

February 28, 2022

Conditions
Smoking CessationPulmonary Disease
Interventions
OTHER

ENDS (vaporizer/e-cig) and smoking cessation counseling

"Participants in the intervention group will receive an ENDS and nicotine-containing e-liquids, which they will be allowed to use ad libitum. Additionally, they will receive standards of care, i.e. smoking cessation counseling and encouragement to use NRT. Smoking cessation counseling will be provided in person at the first clinical visit and then over the phone at the target quit date and again at week 1, 2, 4 and 8 after the target quit date. All participants will be followed over a 6-month period. After 6 months, participants will be asked to come to a final clinical visit.~PFT and MBW will be performed at baseline and after the 6 months follow-up period in all participants of the substudy."

OTHER

Smoking cessation counseling

"Participants in the control group will receive standard of care only, i.e. i.e. smoking cessation counseling and encouragement to use NRT. Smoking cessation counseling will be provided in person at the first clinical visit and then over the phone at the target quit date and again at week 1, 2, 4 and 8 after the target quit date. All participants will be followed over a 6-month period. After 6 months, participants will be asked to come to a final clinical visit.~PFT and MBW will be performed at baseline and after the 6 months follow-up period in all participants of the substudy."

Trial Locations (2)

3010

University Clinic for General Internal Medicine, Bern University Hospital, Bern

Unknown

Department of Pneumology, Bern

All Listed Sponsors
collaborator

Swiss National Science Foundation

OTHER

collaborator

Bernese Lung League

UNKNOWN

collaborator

Insel Gruppe AG, University Hospital Bern

OTHER

lead

University of Bern

OTHER

NCT03938298 - The ESTxENDS Trial: Pulmonary Function Substudy | Biotech Hunter | Biotech Hunter